CEO Interview with Stocks Down Under

TruScreen (ASX:TRU) CEO Juliet Hull, from New Zealand, sat down and spoke to Stocks Down Under about the opportunity for the TruScreen technology in emerging markets to provide a lower cost and more patient-friendly alternative for cervical cancer screening.

In particular, they discussed about the Chinese market, which is expected to be a significant value driver in the coming years.